Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
4(18%)
Results Posted
82%(9 trials)

Phase Distribution

Ph phase_4
1
5%
Ph phase_1
2
9%
Ph not_applicable
16
73%
Ph early_phase_1
1
5%
Ph phase_3
1
5%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
1(4.8%)
Phase 1Safety & dosage
2(9.5%)
Phase 3Large-scale testing
1(4.8%)
Phase 4Post-market surveillance
1(4.8%)
N/ANon-phased studies
16(76.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.7%

11 of 12 finished

Non-Completion Rate

8.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

22

all time

Status Distribution
Active(9)
Completed(11)
Terminated(1)
Other(1)

Detailed Status

Completed11
Enrolling by invitation3
Recruiting3
Not yet recruiting2
Suspended1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.8%)
Phase 12 (9.5%)
Phase 31 (4.8%)
Phase 41 (4.8%)
N/A16 (76.2%)

Trials by Status

suspended15%
withdrawn15%
enrolling_by_invitation314%
completed1150%
not_yet_recruiting29%
recruiting314%
active_not_recruiting15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT06848361Not Applicable

Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management

Enrolling By Invitation
NCT07534670Not Applicable

Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY

Not Yet Recruiting
NCT06658067Not Applicable

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Recruiting
NCT05911256Not Applicable

A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

Enrolling By Invitation
NCT05601583Phase 1

Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Active Not Recruiting
NCT04533646Phase 4

Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes

Completed
NCT05766488Not Applicable

Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

Enrolling By Invitation
NCT04653454Not Applicable

Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus

Completed
NCT04845685Not Applicable

A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus

Suspended
NCT06939413Not Applicable

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

Recruiting
NCT06932289Not Applicable

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

Not Yet Recruiting
NCT03738852Early Phase 1

Mechanisms for Restoration of Hypoglycemia Awareness

Completed
NCT05776563Not Applicable

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

Recruiting
NCT03037671

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

Completed
NCT02572856Not Applicable

Continuous Glucose Monitoring During and After Surgery

Completed
NCT04756141Not Applicable

CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2))

Completed
NCT01586065Not Applicable

Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

Completed
NCT05472220Phase 1

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

Withdrawn
NCT03290768Not Applicable

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

Completed
NCT03427931Not Applicable

CGM Use in Islet Transplant Recipients

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
22